Clinical Trial Update: Diffuse Cutaneous Scleroderma (DSSc) SFDI Study [NA]

View source ↗

Summary

This clinical trial update notes that the Diffuse Cutaneous Scleroderma SFDI study (NCT07090226) sponsored by Boston University is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Systemic Sclerosis

Snippet

Sponsor: Boston University | Conditions: Systemic Scleroderma, Diffuse Cutaneous Scleroderma | NA | Status: RECRUITING